Boehringer Ingelheim, in partnership with the WHO Foundation [an organisation set up to support the World Health Organization ...
Boehringer Ingelheim, a biopharmaceutical company active in ... the company focuses on developing innovative therapies that can improve and extend lives in areas of high unmet medical need. The WHO ...
Hosted by Boehringer Ingelheim, the ‘CRM Summit’, an expert engagement forum, and the ‘IMETA CRM Discussions for EXperts ...
A persistent, often progressive, lung disease, COPD results from chronic inflammation that leads to structural changes ...
Healthcare decision-makers are facing significant challenges that will intensify in the coming years as they work to address ...
Boehringer Ingelheim, Circle Pharma ink research collaboration to develop a novel precision cancer treatment: Ingelheim, Germany Friday, October 11, 2024, 12:00 Hrs [IST] Boehring ...
Boehringer Ingelheim and the WHO Foundation have partnered to promote equitable healthcare access and suicide prevention, with a focus on vulnera ...
Saniona (OMX: SANION), a clinical-stage biopharmaceutical company, today announces that its ongoing ion channel research collaboration with Boehringer Ingelheim has advanced to the lead optimization s ...
Boehringer Ingelheim, a biopharmaceutical company active in both human and animal health, in partnership with WHO Foundation, today pledged USD 5 million to advance access to quality healthcare ...
Boehringer Ingelheim, a biopharmaceutical company active in both human and animal health, in partnership with WHO Foundation, today pledged USD 5 million to advance access to quality healthcare servic ...